Premique Cycle®
Premique Cycle® consists of 0.625mg conjugated estrogen tablets and 0.625mg conjugated estrogens/10mg medroxyprogesterone acetate tablets.
Therapeutic indications:
Hormone replacement therapy for estrogen deficiency symptoms in menopausal and postmenopausal women.
Prevention of osteoporosis in postmenopausal women at high risk of future fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of osteoporosis.
Dosage:
Premique Cycle® is available for oral use in a sequential regimen for treatment of women with a uterus. That is, for the first 14 days of each cycle (days 1-14), one white tablet containing conjugated estrogens 0.625mg is taken daily, and for the last 14 days (days 15-28), one green tablet containing conjugated estrogens 0.625mg and MPA 10mg is taken daily. There should be no break between packs.